Skip to content

Clinical trials

Observational Inflammation trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Observational Country / region: Norway Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20111
20121
20131
20141
20162
20181
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sykehuset Telemark2
Diakonhjemmet Hospital1
Nordlandssykehuset HF1
Norwegian University of Science and Technology1
Oral Health Centre of Expertise in Western Norway1
Oslo University Hospital1
Sara Poletti1
Ullevaal University Hospital1
University of Oslo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation10
Lung Diseases, Obstructive2
Signs and Symptoms, Respiratory2
Atherosclerosis1
Bone Neoplasms1
Cachexia1
Diabetes Mellitus, Type 21
Fatigue Syndrome, Chronic1
Glucose Intolerance1
Ischemic Stroke1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.